Novartis' therapy candidate ianalumab safely and effectively eased disease activity for adults with active Sjögren's in two clinical trials.| Sjogren's Disease News
Levels of the receptor protein Mer tyrosine kinase (MerTK) in small salivary glands may be a useful marker for tracking disease activity and estimating tissue damage in Sjögren’s disease, a study reports. Researchers found that elevated MerTK, which plays a role in immune inflammation, was significantly associated with more disease activity and tissue damage. They […] The post MerTK protein in salivary glands could help track Sjögren’s activity appeared first on Sjogren's Disease News.| Sjogren's Disease News – The Web's Daily Resource for Sjogren's Disease News
Povetacicept reduced disease activity in a mouse model of MG by reducing the levels of disease-causing antibodies in the bloodstream.| Myasthenia Gravis News
CMV viral infections are common among SLE children, but early identification and treatment can improve patient prognosis, a study found.| Lupus News Today
In a study, low TTR blood levels correlated with higher markers of inflammation, low BMI, and higher primary Sjögren's disease activity.| Sjogren's Syndrome News